3079 logo

DVx Inc. Stock Price

TSE:3079 Community·JP¥10.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3079 Share Price Performance

JP¥976.00
52.00 (5.63%)
JP¥976.00
52.00 (5.63%)
Price JP¥976.00

3079 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

DVx Inc. Key Details

JP¥56.0b

Revenue

JP¥50.6b

Cost of Revenue

JP¥5.4b

Gross Profit

JP¥5.1b

Other Expenses

JP¥225.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
21.43
9.58%
0.40%
0.2%
View Full Analysis

About 3079

Founded
1986
Employees
334
CEO
Hiroshi Shibasaki
WebsiteView website
www.dvx.jp

DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in the design, manufacture, and purchasing/selling of medical computers; manufacture, purchasing/selling, repair, maintenance and inspection, rental, leasing, and import/export of medicines, quasi drugs, cosmetics, health foods, daily goods, nursing care products, and nursing care equipment; provision of internal and external medical and medical device-related general consulting and services, as well as medical publishing and market research services; and sale and purchase of second hand goods. The company was incorporated in 1986 and is headquartered in Tokyo, Japan.

Recent 3079 News & Updates

Recent updates

No updates